LABORATORY EXAMINATIONS HEMATOLOGY REPORT Date: August 15, 2011 PARAMETER NORMAL FINDINGS 5-10 x 10^g/L ACTUAL FINDINGS

ANALYSIS
Decreased due to inadequate inflammatory defenses to suppress infection and humoral immunity takes place

White Blood cells

3.98

Hemoglobin Hematocrit Segmenters Lymphocytes Platelet Count

135-180 gms/L 0.35-0.51 0.55-0.65 0.25-0.35 130-500 x 10^g/L

175.4 0.47 0.29 0.50 31 x 10^g/L

Normal Normal
Decreased; indicate low glucose level in the blood Increased due to the bodys increased immune system

Hemolysis

HEMATOLOGY REPORT Date: August 16, 2011

PARAMETER White Blood cells Hemoglobin Hematocrit Segmenters Lymphocytes Platelet Count

NORMAL FINDINGS 5-10 x 10^g/L 135-180 gms/L 0.35-0.51 0.55-0.65 0.25-0.35 130-500 x 10^g/L

ACTUAL FINDINGS 7.25 x 10^g/L 148.4 gms/L 0.40 0.16 0.71 50 x 10^g/L

ANALYSIS Normal Normal Normal

Decreased; indicate low glucose level in the blood Increased due to the bodys increased immune system

Hemolysis

HEMATOLOGY REPORT Date: August 17, 2011

PARAMETER White Blood cells Hemoglobin Hematocrit Segmenters Lymphocytes Platelet Count

NORMAL FINDINGS 5-10 x 10^g/L 135-180 gms/L 0.35-0.51 0.55-0.65 0.25-0.35 130-500 X 10^g/L

ACTUAL FINDINGS 7.11 x 10^g/L 138.4 gms/L 0.37 0.26 0.50 85 x 10^g/L

ANALYSIS Normal Normal Normal

Decreased; indicate low glucose level in the blood Increased due to the bodys increased immune system

Hemolysis

HEMATOLOGY REPORT Date: August 18, 2011

PARAMETER White Blood cells Hemoglobin

NORMAL FINDINGS 5-10 x 10^g/L 135-180 gms/L

ACTUAL FINDINGS 5.87 x 10^g/L 134.18

ANALYSIS Normal
Decreased due to poor oxygen supply

Hematocrit Segmenters Lymphocytes Platelet Count

0.35-0.51 0.55-0.65 0.25-0.35 130-500 X 10^g/L

0.36 0.36 0.39 141 x 10^g/L

Normal
Decreased; indicate low glucose level in the blood Increased due to the bodys increased immune system

Normal

PARAMETER White Blood cells Hemoglobin Hematocrit Segmenters Lymphocytes

HEMATOLOGY REPORT Date: August 19, 2011 NORMAL ACTUAL FINDINGS FINDINGS 5-10 x 10^g/L 135-180 gms/L 0.35-0.51 0.55-0.65 0.25-0.35 7.93 x 10^g/L 143.4 gms/L 0.40 0.40 0.38

ANALYSIS Normal Normal Normal

Decreased; indicate low glucose level in the blood Increased due to the bodys increased immune system

Platelet Count

130-500 X 10^g/L

198 x 10^g/L

Normal

Complete Blood Count (CBC) A complete blood count (CBC), also known as full blood count (FBC) or full blood exam (FBE) or blood panel, is a test panel requested by a doctor or other medical professional that gives information about the cells in a patient's blood. A scientist or lab technician performs the requested testing and provides the requesting medical professsional with the results of the CBC. PURPOSE: The CBC provides valuable information about the blood and to some extent the bone marrow, which is the blood-forming tissue. The CBC is used for the following purposes:

as a preoperative test to ensure both adequate oxygen carrying capacity and hemostasis to identify persons who may have an infection to diagnose anemia to identify acute and chronic illness, bleeding tendencies, and white blood cell disorders such as leukemia to monitor treatment for anemia and other blood diseases to determine the effects of chemotherapy and radiation therapy on blood cell production

Interpretation Certain disease states are defined by an absolute increase or decrease in the number of a particular type of cell in the bloodstream. For example: Type of Cell Increase Decrease

Red Blood Cells

erythrocytosis or polycythemia anemia or erythroblastopenia

White Blood Cells leukocytosis

leukopenia

* lymphocytes

- lymphocytosis

- lymphocytopenia

*granulocytes:

- granulocytosis

granulocytopenia or agranulocytosis

*neutrophils

-neutrophilia

-neutropenia

*eosinophils

-eosinophilia

-eosinopenia

*basophils

-basophilia

-basopenia

Platelets

thrombocytosis

thrombocytopenia

All cell lines

pancytopenia

Many disease states are heralded by changes in the blood count:

leukocytosis can be a sign of infection. thrombocytopenia can result from drug toxicity. pancytopenia is generally as the result of decreased production from the bone marrow, and is a common complication of cancer chemotherapy.